My figures indicate given fixed costs if they can increase sales by 10% they could be back in profit.Given the asset base of the company happy to purchase at this level and be patient.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025